ABCL Competitors & Alternatives
Compare Abcellera Biologics Inc with similar stocks in the same industry
Biotechnology
ABCL
Main Stock$5.97
Tradestie Score
54
Market Cap
$1.78B
Revenue Growth
1.0%
Analyst Upside
+75.9%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CELC
Celcuity Inc. Common Stock
|
$91.69
|
$1.92B | - | 46 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$80.89
|
$1.90B | 481.8 | 52 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$37.17
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$34.48
|
$1.81B | - | 56 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$23.83
|
$1.78B | - | 56 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.18
|
$1.74B | - | 56 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$35.66
|
$1.68B | - | 52 | Compare |
|
MNKD
Mannkind Corporation
|
$4.05
|
$1.65B | - | 53 | Compare |
|
MPLT
MPLT
|
$37.44
|
$1.63B | - | 57 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.58
|
$1.63B | - | 47 | Compare |
More ABCL Analysis
Data updated: Jul 21, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry